Patent AnalyticsExaminers
Menu

Topic

Cancer immunotherapy Steady

462 applications whose title mentions it. Its share of new filings over the last two years is 4% above the four years before.

Allowance rate
63%
−13 pts vs the USPTO 331 decided
Months to first action
20.8 mo
+2.2 vs the USPTO
Applications
462.0
in the record
Allowed
207.0
124 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Applications

Recent applications on this topic

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19626379METHODS FOR SELECTING CANCER PATIENTS FOR IMMUNOTHERAPY USING SUBCLONAL MUTATION AN…2026-09-21Pending00n/a
19625971IMMUNOTHERAPY FOR OX40 EXPRESSING CANCER2026-09-20Pending00n/a
19617056ANTICANCER ADJUVANT FOR CANCER IMMUNOTHERAPY AND COMPOSITION FOR INHIBITING CANCER …2026-08-20Pending00n/a
15271096Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15482005Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15577771Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15970477Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15405394Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15124332Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15559996Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in